Reuters logo
BRIEF-Bavarian Nordic says independent Data Monitoring Committee determined continuation of Phase 3 prospect study of Prostvac is futile
September 14, 2017 / 8:21 PM / 6 days ago

BRIEF-Bavarian Nordic says independent Data Monitoring Committee determined continuation of Phase 3 prospect study of Prostvac is futile

Sept 14 (Reuters) - Bavarian Nordic A/S -

* Independent Data Monitoring Committee recommends discontinuation of Bavarian Nordic’s Phase 3 study of Prostvac in metastatic prostate cancer

* An independent Data Monitoring Committee determined continuation of Phase 3 prospect study of Prostvac is futile

* Contents of this announcement do not affect the company’s expectations for the financial results for 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below